IL‐1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?

Authors:

Abstract
This minireview gets an insight into recent findings on the implication of IL‐1ra and its gene polymorphism in diabetes and obesity, discusses the potential dual effects of IL‐1ra observed in different models, and comments on future directions.

This publication has 70 references indexed in Scilit: